Caricamento...
Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
Purpose: Pancreatic ductal adenocarcinoma (PDAC) with difficulty in early diagnosis does not respond well to conventional treatments and has not occurred significant improvement in the overall 5-year survival rates. Mesothelin (MSLN) is a tumor differentiation antigen expressed in several solid neop...
Salvato in:
| Pubblicato in: | Int J Med Sci |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Ivyspring International Publisher
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7053310/ https://ncbi.nlm.nih.gov/pubmed/32174772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.39012 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|